Abstract |
Gestrinone has been shown to reduce uterine volume and stop bleeding in women with uterine leiomyomata. In the present study, we demonstrated a reduction in the volume of uterine myomas and in the uterine artery blood perfusion over a 6-month period of gestrinone administration in premenopausal women.
|
Authors | Antonio La Marca, Simone Giulini, Giovanni Vito, Raoul Orvieto, Annibale Volpe, Valerio Maria Jasonni |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 82
Issue 6
Pg. 1694-6
(Dec 2004)
ISSN: 0015-0282 [Print] United States |
PMID | 15589885
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Estrogen Antagonists
- Gestrinone
|
Topics |
- Adult
- Estrogen Antagonists
(therapeutic use)
- Female
- Gestrinone
(therapeutic use)
- Humans
- Leiomyomatosis
(blood supply, diagnostic imaging, drug therapy)
- Premenopause
- Regional Blood Flow
(drug effects)
- Time Factors
- Treatment Outcome
- Ultrasonography
- Uterine Neoplasms
(blood supply, diagnostic imaging, drug therapy)
|